nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic lupus erythematosus	0.706	1	CiPCiCtD
Clofarabine—ABCG2—Leflunomide—systemic lupus erythematosus	0.0565	0.319	CbGbCtD
Clofarabine—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0349	0.197	CbGbCtD
Clofarabine—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.028	0.158	CbGbCtD
Clofarabine—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0265	0.149	CbGbCtD
Clofarabine—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0174	0.0983	CbGbCtD
Clofarabine—ABCG2—Methotrexate—systemic lupus erythematosus	0.014	0.079	CbGbCtD
Clofarabine—Cytarabine—POLB—systemic lupus erythematosus	0.00177	1	CrCbGaD
Clofarabine—RRM1—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.00153	0.178	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.00126	0.147	CbGpPWpGaD
Clofarabine—RRM2—skin of body—systemic lupus erythematosus	0.00108	0.0499	CbGeAlD
Clofarabine—RRM2—kidney—systemic lupus erythematosus	0.00102	0.0471	CbGeAlD
Clofarabine—RRM1—nephron tubule—systemic lupus erythematosus	0.00096	0.0445	CbGeAlD
Clofarabine—RRM1—skin of body—systemic lupus erythematosus	0.000895	0.0415	CbGeAlD
Clofarabine—RRM2—lymphoid tissue—systemic lupus erythematosus	0.000872	0.0404	CbGeAlD
Clofarabine—POLA1—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.000863	0.1	CbGpPWpGaD
Clofarabine—POLA1—tendon—systemic lupus erythematosus	0.000858	0.0398	CbGeAlD
Clofarabine—RRM1—kidney—systemic lupus erythematosus	0.000844	0.0391	CbGeAlD
Clofarabine—POLA1—bone marrow—systemic lupus erythematosus	0.000831	0.0385	CbGeAlD
Clofarabine—RRM1—cortex of kidney—systemic lupus erythematosus	0.000822	0.0381	CbGeAlD
Clofarabine—RRM2—tendon—systemic lupus erythematosus	0.00082	0.038	CbGeAlD
Clofarabine—RRM2—bone marrow—systemic lupus erythematosus	0.000794	0.0368	CbGeAlD
Clofarabine—POLA1—lung—systemic lupus erythematosus	0.000753	0.0349	CbGeAlD
Clofarabine—DCK—nephron tubule—systemic lupus erythematosus	0.000746	0.0346	CbGeAlD
Clofarabine—RRM1—lymphoid tissue—systemic lupus erythematosus	0.000725	0.0336	CbGeAlD
Clofarabine—RRM2—lung—systemic lupus erythematosus	0.00072	0.0333	CbGeAlD
Clofarabine—RRM1—tendon—systemic lupus erythematosus	0.000681	0.0316	CbGeAlD
Clofarabine—RRM2—nervous system—systemic lupus erythematosus	0.000666	0.0309	CbGeAlD
Clofarabine—RRM1—bone marrow—systemic lupus erythematosus	0.00066	0.0306	CbGeAlD
Clofarabine—RRM2—central nervous system—systemic lupus erythematosus	0.000642	0.0297	CbGeAlD
Clofarabine—DCK—cortex of kidney—systemic lupus erythematosus	0.000638	0.0296	CbGeAlD
Clofarabine—RRM1—lung—systemic lupus erythematosus	0.000598	0.0277	CbGeAlD
Clofarabine—DCK—lymphoid tissue—systemic lupus erythematosus	0.000563	0.0261	CbGeAlD
Clofarabine—RRM1—nervous system—systemic lupus erythematosus	0.000554	0.0257	CbGeAlD
Clofarabine—RRM1—central nervous system—systemic lupus erythematosus	0.000533	0.0247	CbGeAlD
Clofarabine—DCK—tendon—systemic lupus erythematosus	0.000529	0.0245	CbGeAlD
Clofarabine—DCK—bone marrow—systemic lupus erythematosus	0.000512	0.0238	CbGeAlD
Clofarabine—DCK—lung—systemic lupus erythematosus	0.000464	0.0215	CbGeAlD
Clofarabine—DCK—nervous system—systemic lupus erythematosus	0.00043	0.0199	CbGeAlD
Clofarabine—ABCG2—nephron tubule—systemic lupus erythematosus	0.000416	0.0193	CbGeAlD
Clofarabine—DCK—central nervous system—systemic lupus erythematosus	0.000414	0.0192	CbGeAlD
Clofarabine—ABCG2—bone marrow—systemic lupus erythematosus	0.000286	0.0133	CbGeAlD
Clofarabine—ABCG2—lung—systemic lupus erythematosus	0.000259	0.012	CbGeAlD
Clofarabine—POLA1—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000216	0.115	CbGdCrCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000186	0.0216	CbGpPWpGaD
Clofarabine—POLA1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000172	0.0918	CbGdCrCtD
Clofarabine—POLA1—Telomere Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000164	0.0191	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000153	0.0178	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000152	0.0176	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000143	0.0166	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000137	0.0159	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	0.000121	0.0647	CbGdCrCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000115	0.0134	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	0.000115	0.0611	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Dexamethasone—systemic lupus erythematosus	0.000113	0.0601	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Betamethasone—systemic lupus erythematosus	0.000113	0.0601	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Methylprednisolone—systemic lupus erythematosus	0.000111	0.0593	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Triamcinolone—systemic lupus erythematosus	0.00011	0.0587	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—systemic lupus erythematosus	0.000109	0.0583	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Dexamethasone—systemic lupus erythematosus	0.000109	0.0583	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Triamcinolone—systemic lupus erythematosus	0.000107	0.057	CbGdCrCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000106	0.0123	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000105	0.0122	CbGpPWpGaD
Clofarabine—DCK—Desoximetasone—Prednisone—systemic lupus erythematosus	0.000105	0.0557	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisolone—systemic lupus erythematosus	0.000102	0.0544	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—systemic lupus erythematosus	0.000102	0.0541	CbGdCrCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	9.97e-05	0.0116	CbGpPWpGaD
Clofarabine—DCK—Diflorasone—Prednisolone—systemic lupus erythematosus	9.91e-05	0.0528	CbGdCrCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	9.67e-05	0.0112	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	8.93e-05	0.0104	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	8.88e-05	0.0103	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	8.74e-05	0.0102	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	8.19e-05	0.00952	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—EP300—systemic lupus erythematosus	7.79e-05	0.00906	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	7.71e-05	0.00896	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	7.32e-05	0.00851	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	7.31e-05	0.00849	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	7.16e-05	0.00832	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	7.12e-05	0.00827	CbGpPWpGaD
Clofarabine—DCK—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	7.1e-05	0.0378	CbGdCrCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	6.9e-05	0.00802	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	6.75e-05	0.00784	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—EP300—systemic lupus erythematosus	6.42e-05	0.00746	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	6.35e-05	0.00738	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	5.96e-05	0.00692	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	5.94e-05	0.0069	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	5.86e-05	0.00681	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	5.68e-05	0.00661	CbGpPWpGaD
Clofarabine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	5.68e-05	0.000691	CcSEcCtD
Clofarabine—Vomiting—Leflunomide—systemic lupus erythematosus	5.68e-05	0.000691	CcSEcCtD
Clofarabine—Alopecia—Prednisone—systemic lupus erythematosus	5.67e-05	0.00069	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	5.65e-05	0.000687	CcSEcCtD
Clofarabine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	5.65e-05	0.000687	CcSEcCtD
Clofarabine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	5.64e-05	0.000686	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000686	CcSEcCtD
Clofarabine—Paraesthesia—Prednisolone—systemic lupus erythematosus	5.64e-05	0.000686	CcSEcCtD
Clofarabine—Rash—Leflunomide—systemic lupus erythematosus	5.64e-05	0.000685	CcSEcCtD
Clofarabine—Tachycardia—Triamcinolone—systemic lupus erythematosus	5.63e-05	0.000685	CcSEcCtD
Clofarabine—Dermatitis—Leflunomide—systemic lupus erythematosus	5.63e-05	0.000685	CcSEcCtD
Clofarabine—Mental disorder—Prednisone—systemic lupus erythematosus	5.62e-05	0.000684	CcSEcCtD
Clofarabine—Nausea—Azathioprine—systemic lupus erythematosus	5.62e-05	0.000684	CcSEcCtD
Clofarabine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	5.62e-05	0.000684	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.62e-05	0.00653	CbGpPWpGaD
Clofarabine—Headache—Leflunomide—systemic lupus erythematosus	5.6e-05	0.000681	CcSEcCtD
Clofarabine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	5.59e-05	0.00068	CcSEcCtD
Clofarabine—Erythema—Prednisone—systemic lupus erythematosus	5.59e-05	0.00068	CcSEcCtD
Clofarabine—Malnutrition—Prednisone—systemic lupus erythematosus	5.59e-05	0.00068	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	5.59e-05	0.000679	CcSEcCtD
Clofarabine—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	5.58e-05	0.000679	CcSEcCtD
Clofarabine—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	5.57e-05	0.000677	CcSEcCtD
Clofarabine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	5.55e-05	0.000674	CcSEcCtD
Clofarabine—Hypertension—Betamethasone—systemic lupus erythematosus	5.54e-05	0.000674	CcSEcCtD
Clofarabine—Hypertension—Dexamethasone—systemic lupus erythematosus	5.54e-05	0.000674	CcSEcCtD
Clofarabine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	5.5e-05	0.000669	CcSEcCtD
Clofarabine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.5e-05	0.000669	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	5.48e-05	0.00636	CbGpPWpGaD
Clofarabine—Myalgia—Betamethasone—systemic lupus erythematosus	5.46e-05	0.000664	CcSEcCtD
Clofarabine—Myalgia—Dexamethasone—systemic lupus erythematosus	5.46e-05	0.000664	CcSEcCtD
Clofarabine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	5.45e-05	0.000663	CcSEcCtD
Clofarabine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	5.45e-05	0.000663	CcSEcCtD
Clofarabine—Anxiety—Betamethasone—systemic lupus erythematosus	5.44e-05	0.000662	CcSEcCtD
Clofarabine—Anxiety—Dexamethasone—systemic lupus erythematosus	5.44e-05	0.000662	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—systemic lupus erythematosus	5.39e-05	0.000656	CcSEcCtD
Clofarabine—Hypotension—Methylprednisolone—systemic lupus erythematosus	5.38e-05	0.000655	CcSEcCtD
Clofarabine—Pain—Prednisolone—systemic lupus erythematosus	5.37e-05	0.000653	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—systemic lupus erythematosus	5.37e-05	0.000653	CcSEcCtD
Clofarabine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.33e-05	0.000648	CcSEcCtD
Clofarabine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.32e-05	0.000647	CcSEcCtD
Clofarabine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.32e-05	0.000647	CcSEcCtD
Clofarabine—Nausea—Leflunomide—systemic lupus erythematosus	5.31e-05	0.000646	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CDKN1B—systemic lupus erythematosus	5.3e-05	0.00616	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	5.3e-05	0.000644	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.29e-05	0.000644	CcSEcCtD
Clofarabine—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.29e-05	0.000643	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—systemic lupus erythematosus	5.26e-05	0.00064	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.26e-05	0.00064	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.25e-05	0.000638	CcSEcCtD
Clofarabine—Pain—Hydrocortisone—systemic lupus erythematosus	5.24e-05	0.000638	CcSEcCtD
Clofarabine—Oedema—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000637	CcSEcCtD
Clofarabine—Oedema—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000637	CcSEcCtD
Clofarabine—Infection—Betamethasone—systemic lupus erythematosus	5.2e-05	0.000633	CcSEcCtD
Clofarabine—Infection—Dexamethasone—systemic lupus erythematosus	5.2e-05	0.000633	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	5.2e-05	0.00604	CbGpPWpGaD
Clofarabine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.18e-05	0.00063	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.17e-05	0.000629	CcSEcCtD
Clofarabine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.17e-05	0.000629	CcSEcCtD
Clofarabine—Anaemia—Prednisone—systemic lupus erythematosus	5.17e-05	0.000628	CcSEcCtD
Clofarabine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.15e-05	0.000626	CcSEcCtD
Clofarabine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.14e-05	0.000625	CcSEcCtD
Clofarabine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.14e-05	0.000625	CcSEcCtD
Clofarabine—Agitation—Prednisone—systemic lupus erythematosus	5.14e-05	0.000625	CcSEcCtD
Clofarabine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.13e-05	0.000624	CcSEcCtD
Clofarabine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.13e-05	0.000624	CcSEcCtD
Clofarabine—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.11e-05	0.000622	CcSEcCtD
Clofarabine—Tachycardia—Betamethasone—systemic lupus erythematosus	5.11e-05	0.000622	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	5.08e-05	0.00591	CbGpPWpGaD
Clofarabine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	5.08e-05	0.000618	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	5.07e-05	0.000617	CcSEcCtD
Clofarabine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.06e-05	0.000616	CcSEcCtD
Clofarabine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.06e-05	0.000616	CcSEcCtD
Clofarabine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5.05e-05	0.000614	CcSEcCtD
Clofarabine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.00061	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	5e-05	0.00581	CbGpPWpGaD
Clofarabine—Anorexia—Dexamethasone—systemic lupus erythematosus	4.99e-05	0.000607	CcSEcCtD
Clofarabine—Anorexia—Betamethasone—systemic lupus erythematosus	4.99e-05	0.000607	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.98e-05	0.000606	CcSEcCtD
Clofarabine—Fatigue—Triamcinolone—systemic lupus erythematosus	4.98e-05	0.000605	CcSEcCtD
Clofarabine—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.97e-05	0.000604	CcSEcCtD
Clofarabine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.96e-05	0.000603	CcSEcCtD
Clofarabine—Asthenia—Cyclosporine—systemic lupus erythematosus	4.95e-05	0.000602	CcSEcCtD
Clofarabine—Pain—Triamcinolone—systemic lupus erythematosus	4.94e-05	0.0006	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.92e-05	0.00572	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDKN1A—systemic lupus erythematosus	4.89e-05	0.00569	CbGpPWpGaD
Clofarabine—Hypotension—Betamethasone—systemic lupus erythematosus	4.89e-05	0.000595	CcSEcCtD
Clofarabine—Hypotension—Dexamethasone—systemic lupus erythematosus	4.89e-05	0.000595	CcSEcCtD
Clofarabine—Pruritus—Cyclosporine—systemic lupus erythematosus	4.88e-05	0.000594	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000592	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.85e-05	0.000589	CcSEcCtD
Clofarabine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.85e-05	0.000589	CcSEcCtD
Clofarabine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.85e-05	0.000589	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.84e-05	0.000588	CcSEcCtD
Clofarabine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000587	CcSEcCtD
Clofarabine—Hypertension—Prednisone—systemic lupus erythematosus	4.83e-05	0.000587	CcSEcCtD
Clofarabine—Chills—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000586	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.77e-05	0.00058	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.77e-05	0.00058	CcSEcCtD
Clofarabine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.76e-05	0.000579	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—systemic lupus erythematosus	4.76e-05	0.000579	CcSEcCtD
Clofarabine—Myalgia—Prednisone—systemic lupus erythematosus	4.76e-05	0.000579	CcSEcCtD
Clofarabine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.76e-05	0.000579	CcSEcCtD
Clofarabine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.75e-05	0.000577	CcSEcCtD
Clofarabine—Anxiety—Prednisone—systemic lupus erythematosus	4.74e-05	0.000577	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000577	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.73e-05	0.000575	CcSEcCtD
Clofarabine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.72e-05	0.000574	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.71e-05	0.000573	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.7e-05	0.000572	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.7e-05	0.000572	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000572	CcSEcCtD
Clofarabine—Erythema—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000568	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000568	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.62e-05	0.000562	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	4.61e-05	0.00536	CbGpPWpGaD
Clofarabine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.6e-05	0.00056	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.56e-05	0.000555	CcSEcCtD
Clofarabine—Dizziness—Cyclosporine—systemic lupus erythematosus	4.56e-05	0.000555	CcSEcCtD
Clofarabine—Oedema—Prednisone—systemic lupus erythematosus	4.56e-05	0.000555	CcSEcCtD
Clofarabine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.55e-05	0.000554	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.55e-05	0.000554	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.55e-05	0.000554	CcSEcCtD
Clofarabine—Infection—Prednisone—systemic lupus erythematosus	4.53e-05	0.000551	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.52e-05	0.00055	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.52e-05	0.00055	CcSEcCtD
Clofarabine—Back pain—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000549	CcSEcCtD
Clofarabine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.52e-05	0.000549	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—systemic lupus erythematosus	4.52e-05	0.000549	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—systemic lupus erythematosus	4.52e-05	0.000549	CcSEcCtD
Clofarabine—Pain—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000545	CcSEcCtD
Clofarabine—Pain—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000545	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.47e-05	0.000544	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	4.47e-05	0.00519	CbGpPWpGaD
Clofarabine—Tachycardia—Prednisone—systemic lupus erythematosus	4.45e-05	0.000541	CcSEcCtD
Clofarabine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.45e-05	0.000541	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—systemic lupus erythematosus	4.43e-05	0.000539	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	4.42e-05	0.00514	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.41e-05	0.000536	CcSEcCtD
Clofarabine—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000535	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—EP300—systemic lupus erythematosus	4.39e-05	0.0051	CbGpPWpGaD
Clofarabine—Vomiting—Cyclosporine—systemic lupus erythematosus	4.39e-05	0.000533	CcSEcCtD
Clofarabine—Rash—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000529	CcSEcCtD
Clofarabine—Anorexia—Prednisone—systemic lupus erythematosus	4.35e-05	0.000529	CcSEcCtD
Clofarabine—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000528	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	4.34e-05	0.00505	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.34e-05	0.00504	CbGpPWpGaD
Clofarabine—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.34e-05	0.000527	CcSEcCtD
Clofarabine—Headache—Cyclosporine—systemic lupus erythematosus	4.32e-05	0.000526	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000525	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.32e-05	0.000525	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.32e-05	0.000525	CcSEcCtD
Clofarabine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.28e-05	0.000521	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.000521	CcSEcCtD
Clofarabine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.28e-05	0.00052	CcSEcCtD
Clofarabine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.25e-05	0.000517	CcSEcCtD
Clofarabine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.24e-05	0.000516	CcSEcCtD
Clofarabine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.000516	CcSEcCtD
Clofarabine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.000516	CcSEcCtD
Clofarabine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.22e-05	0.000513	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	4.2e-05	0.00488	CbGpPWpGaD
Clofarabine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.19e-05	0.00051	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.19e-05	0.00487	CbGpPWpGaD
Clofarabine—Leukopenia—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000508	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.16e-05	0.000505	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—systemic lupus erythematosus	4.15e-05	0.000505	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—systemic lupus erythematosus	4.14e-05	0.000504	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000504	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000504	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000504	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000504	CcSEcCtD
Clofarabine—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.000503	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	4.12e-05	0.00479	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.11e-05	0.00478	CbGpPWpGaD
Clofarabine—Nausea—Cyclosporine—systemic lupus erythematosus	4.1e-05	0.000498	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—systemic lupus erythematosus	4.1e-05	0.000498	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—systemic lupus erythematosus	4.08e-05	0.000497	CcSEcCtD
Clofarabine—Cough—Methotrexate—systemic lupus erythematosus	4.08e-05	0.000496	CcSEcCtD
Clofarabine—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.07e-05	0.000496	CcSEcCtD
Clofarabine—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.05e-05	0.000493	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.03e-05	0.00469	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	4.02e-05	0.00467	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	4.01e-05	0.00466	CbGpPWpGaD
Clofarabine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4e-05	0.000486	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000484	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000484	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—systemic lupus erythematosus	3.97e-05	0.000482	CcSEcCtD
Clofarabine—Rash—Prednisolone—systemic lupus erythematosus	3.96e-05	0.000481	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—systemic lupus erythematosus	3.95e-05	0.000481	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.95e-05	0.00048	CcSEcCtD
Clofarabine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.94e-05	0.000479	CcSEcCtD
Clofarabine—Fatigue—Prednisone—systemic lupus erythematosus	3.93e-05	0.000478	CcSEcCtD
Clofarabine—Headache—Prednisolone—systemic lupus erythematosus	3.93e-05	0.000478	CcSEcCtD
Clofarabine—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.9e-05	0.000474	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	3.89e-05	0.00452	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.89e-05	0.00452	CbGpPWpGaD
Clofarabine—Rash—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.00047	CcSEcCtD
Clofarabine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.00047	CcSEcCtD
Clofarabine—Headache—Hydrocortisone—systemic lupus erythematosus	3.84e-05	0.000467	CcSEcCtD
Clofarabine—Dizziness—Triamcinolone—systemic lupus erythematosus	3.82e-05	0.000464	CcSEcCtD
Clofarabine—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.81e-05	0.000463	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.79e-05	0.00441	CbGpPWpGaD
Clofarabine—Infection—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000461	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1B—systemic lupus erythematosus	3.77e-05	0.00438	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	3.76e-05	0.00437	CbGpPWpGaD
Clofarabine—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.76e-05	0.000457	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000457	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000457	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000455	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.73e-05	0.000454	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.73e-05	0.000454	CcSEcCtD
Clofarabine—Nausea—Prednisolone—systemic lupus erythematosus	3.73e-05	0.000453	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	3.71e-05	0.00431	CbGpPWpGaD
Clofarabine—Pruritus—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000451	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000451	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—systemic lupus erythematosus	3.7e-05	0.00045	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000448	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—systemic lupus erythematosus	3.67e-05	0.000446	CcSEcCtD
Clofarabine—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.66e-05	0.000445	CcSEcCtD
Clofarabine—Nausea—Hydrocortisone—systemic lupus erythematosus	3.64e-05	0.000443	CcSEcCtD
Clofarabine—Rash—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000443	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000442	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—systemic lupus erythematosus	3.63e-05	0.000442	CcSEcCtD
Clofarabine—Rash—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000442	CcSEcCtD
Clofarabine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000441	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1B—systemic lupus erythematosus	3.63e-05	0.00421	CbGpPWpGaD
Clofarabine—Headache—Triamcinolone—systemic lupus erythematosus	3.62e-05	0.00044	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.61e-05	0.0042	CbGpPWpGaD
Clofarabine—Headache—Methylprednisolone—systemic lupus erythematosus	3.61e-05	0.000439	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—systemic lupus erythematosus	3.61e-05	0.000439	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—systemic lupus erythematosus	3.61e-05	0.000439	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.58e-05	0.000436	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.58e-05	0.000436	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000433	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	3.48e-05	0.00404	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDKN1A—systemic lupus erythematosus	3.48e-05	0.00404	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.47e-05	0.000422	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—systemic lupus erythematosus	3.46e-05	0.000421	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—systemic lupus erythematosus	3.46e-05	0.000421	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—systemic lupus erythematosus	3.43e-05	0.000417	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000416	CcSEcCtD
Clofarabine—Nausea—Methylprednisolone—systemic lupus erythematosus	3.42e-05	0.000416	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.42e-05	0.00397	CbGpPWpGaD
Clofarabine—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000413	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000412	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.36e-05	0.000409	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1A—systemic lupus erythematosus	3.35e-05	0.00389	CbGpPWpGaD
Clofarabine—Vomiting—Betamethasone—systemic lupus erythematosus	3.33e-05	0.000405	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—systemic lupus erythematosus	3.33e-05	0.000405	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000403	CcSEcCtD
Clofarabine—Rash—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000402	CcSEcCtD
Clofarabine—Rash—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000402	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000401	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000401	CcSEcCtD
Clofarabine—POLA1—S Phase—CDKN1B—systemic lupus erythematosus	3.29e-05	0.00383	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.29e-05	0.0004	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—systemic lupus erythematosus	3.29e-05	0.0004	CcSEcCtD
Clofarabine—Headache—Betamethasone—systemic lupus erythematosus	3.28e-05	0.000399	CcSEcCtD
Clofarabine—Headache—Dexamethasone—systemic lupus erythematosus	3.28e-05	0.000399	CcSEcCtD
Clofarabine—Asthenia—Prednisone—systemic lupus erythematosus	3.27e-05	0.000398	CcSEcCtD
Clofarabine—Pain—Methotrexate—systemic lupus erythematosus	3.26e-05	0.000396	CcSEcCtD
Clofarabine—Pruritus—Prednisone—systemic lupus erythematosus	3.23e-05	0.000392	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.14e-05	0.000382	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.14e-05	0.00365	CbGpPWpGaD
Clofarabine—Diarrhoea—Prednisone—systemic lupus erythematosus	3.12e-05	0.00038	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.12e-05	0.000379	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—systemic lupus erythematosus	3.11e-05	0.000378	CcSEcCtD
Clofarabine—Nausea—Betamethasone—systemic lupus erythematosus	3.11e-05	0.000378	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	3.06e-05	0.00355	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1A—systemic lupus erythematosus	3.04e-05	0.00353	CbGpPWpGaD
Clofarabine—Dizziness—Prednisone—systemic lupus erythematosus	3.02e-05	0.000367	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000366	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000366	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.93e-05	0.00341	CbGpPWpGaD
Clofarabine—Vomiting—Prednisone—systemic lupus erythematosus	2.9e-05	0.000353	CcSEcCtD
Clofarabine—RRM1—Metabolism—NAT2—systemic lupus erythematosus	2.9e-05	0.00337	CbGpPWpGaD
Clofarabine—Rash—Prednisone—systemic lupus erythematosus	2.88e-05	0.00035	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—systemic lupus erythematosus	2.87e-05	0.000349	CcSEcCtD
Clofarabine—Headache—Prednisone—systemic lupus erythematosus	2.86e-05	0.000348	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	2.82e-05	0.00328	CbGpPWpGaD
Clofarabine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000342	CcSEcCtD
Clofarabine—Asthenia—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000333	CcSEcCtD
Clofarabine—Nausea—Prednisone—systemic lupus erythematosus	2.71e-05	0.00033	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000328	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000317	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2.6e-05	0.00302	CbGpPWpGaD
Clofarabine—Dizziness—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000307	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	2.46e-05	0.00286	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.45e-05	0.00284	CbGpPWpGaD
Clofarabine—Vomiting—Methotrexate—systemic lupus erythematosus	2.42e-05	0.000295	CcSEcCtD
Clofarabine—Rash—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000292	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000292	CcSEcCtD
Clofarabine—Headache—Methotrexate—systemic lupus erythematosus	2.39e-05	0.00029	CcSEcCtD
Clofarabine—RRM2—Metabolism—NAT2—systemic lupus erythematosus	2.39e-05	0.00277	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.32e-05	0.00269	CbGpPWpGaD
Clofarabine—Nausea—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000275	CcSEcCtD
Clofarabine—DCK—Metabolism—NAT2—systemic lupus erythematosus	2.23e-05	0.00259	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.14e-05	0.00248	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.03e-05	0.00236	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.93e-05	0.00224	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.77e-05	0.00205	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.65e-05	0.00192	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.64e-05	0.0019	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—RXRA—systemic lupus erythematosus	1.63e-05	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.51e-05	0.00176	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—systemic lupus erythematosus	1.47e-05	0.0017	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	1.44e-05	0.00167	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—systemic lupus erythematosus	1.35e-05	0.00157	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—RXRA—systemic lupus erythematosus	1.34e-05	0.00156	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—systemic lupus erythematosus	1.29e-05	0.0015	CbGpPWpGaD
Clofarabine—DCK—Metabolism—RXRA—systemic lupus erythematosus	1.25e-05	0.00145	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.12e-05	0.0013	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.07e-05	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	1.03e-05	0.0012	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—systemic lupus erythematosus	1.03e-05	0.00119	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—systemic lupus erythematosus	1e-05	0.00116	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	9.84e-06	0.00114	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—systemic lupus erythematosus	9.25e-06	0.00107	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—systemic lupus erythematosus	9.23e-06	0.00107	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	8.93e-06	0.00104	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NOS3—systemic lupus erythematosus	8.83e-06	0.00103	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—systemic lupus erythematosus	8.8e-06	0.00102	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—systemic lupus erythematosus	8.45e-06	0.000982	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—systemic lupus erythematosus	8.07e-06	0.000938	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—systemic lupus erythematosus	7.9e-06	0.000918	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—systemic lupus erythematosus	7.6e-06	0.000883	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NOS3—systemic lupus erythematosus	7.27e-06	0.000845	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—systemic lupus erythematosus	7.1e-06	0.000825	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NOS3—systemic lupus erythematosus	6.79e-06	0.000789	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—systemic lupus erythematosus	6.71e-06	0.00078	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—systemic lupus erythematosus	6.65e-06	0.000772	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—systemic lupus erythematosus	6.21e-06	0.000722	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.07e-06	0.000705	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—systemic lupus erythematosus	5.53e-06	0.000642	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—systemic lupus erythematosus	5.17e-06	0.0006	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	5.01e-06	0.000582	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	3.16e-06	0.000367	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—systemic lupus erythematosus	2.84e-06	0.00033	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	2.72e-06	0.000316	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	2.49e-06	0.000289	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.07e-06	0.00024	CbGpPWpGaD
